The pathophysiology of AD is multifactorial, involving interactions among hereditary predisposition, epidermal barrier defects - particularly filaggrin gene mutations - microbiome dysbiosis, and type 2 cytokine-driven inflammation mediated by interleukins (IL-4, IL-13, IL-31) [3]. This evidence concerns the gene IL4 and Alzheimer disease.